Findings lay groundwork for human clinical trial planned for August 2016
A new scientific study has identified why colorectal cancer cells depend on a specific nutrient, and a way to starve them of it. Over one million men and women are living with colorectal cancer in the United States. The National Cancer Institute estimates 4.5% of all men and women will be diagnosed with the cancer during their lifetime, making it the third most common non-skin cancer.
In the study published online in Nature Communications, researchers showed how certain colorectal cancer cells reprogram their metabolism using glutamine, a non-essential amino acid. Many cancer cells rely on glutamine to survive. How they become so dependent on the molecule is hotly debated in the field.
Researchers studied a subset of colorectal cancer cells containing a genetic mutation called PIK3CA. This mutation is located in a gene critical for cell division and movement, and is found in approximately one third of all colorectal cancers. The mutation is also the most commonly identified genetic mutation across all cancers, making the results of the study universally appealing.
Researchers were interested in determining whether or not the common PIK3CA mutation contributes to changes in cancer cell metabolism, such as how nutrients like glutamine are processed. Normally, glutamine is broken down by cancer cells into several other molecules with the help of specific enzymes. This complicated system helps produce adenosine triphosphate, the energy currency of all cells, and other molecules critical for colorectal cancer cell growth.
The researchers found that colorectal cells with the PIK3CA mutation broke down significantly more glutamine than cells without the mutation. The researchers identified several enzymes involved in the process that are more active in the mutant cancer cells than in other cell types, explaining the increased need for glutamine. These enzymes become overactive in the mutant cancer cells due to a cascade of signals led by the protein encoded by mutant PIK3CA gene. This finding represents a novel and important link between the common PIK3CA mutation and altered glutamine metabolism in cancer cells.
Zhenghe John Wang, PhD, professor of genetics and genome sciences and co-leader of the Cancer Genetics Program at Case Western Reserve University School of Medicine helped lead the study. “In layman’s terms, we discovered that colon cancers with PIK3CA oncogenic mutations are addicted to glutamine, a particular nutrient for cancer cells. We also demonstrated that these cancers can be starved to death by depriving glutamine with drugs.”
When the researchers lowered the amount of glutamine available to mutant cancer cells growing in laboratory dishes, the cancer cells died. This discovery led the team to investigate the effects of blocking glutamine availability in mice with colorectal cancer tumors containing the common PIK3CA mutation. Wang and colleagues found that exposing these mice to a compound that blocks glutamine metabolism consistently suppressed tumor growth. They did not observe the same effect on tumors without the mutation. Together, these results provide a promising new therapeutic avenue to suppress growth of colorectal tumors with the PIK3CA mutation. The researchers have filed a patent application based on the unique mechanism of tumor suppression they have identified and the work is available for licensing.
“This study provides the basis for a colon cancer treatment clinical trial that will be started in the summer at the University Hospitals Seidman Cancer Center,” according to Neal Meropol, MD, Dr. Lester E. Coleman, Jr. Professor of Cancer Research and Therapeutics, chief of the division of hematology and oncology, and principal investigator for the trial. The phase I/II study will test the effects of a glutamine metabolism inhibitor in patients with advanced colorectal tumors.
The Latest on: Colorectal cancers
via Google News
The Latest on: Colorectal cancers
Honey from strawberry trees stops cell proliferation in colon cancer lines
on May 20, 2019 at 11:30 pm
Spanish and Italian researchers have proven that when honey from strawberry trees, a product typical of Mediterranean areas, is added to colon cancer cells grown in the laboratory, cell proliferation ... […]
Cholesterol meds will not spur growth of prostate cancer
on May 20, 2019 at 11:06 pm
They have not been used for very long, but I found no evidence that these drugs increase cancer risk either. There was some concern that the increase in bile acids seen in people treated with these ... […]
Fox Chase Cancer Center Colorectal Cancer Facebook LIVE chat
on May 20, 2019 at 1:36 pm
Colorectal cancer is the third most common cancer diagnosed in both men and women in the United States, excluding skin cancers. But, it's also one of the most preventable types of cancers. ... […]
Strawberry tree honey inhibits cell proliferation in colon cancer lines
on May 20, 2019 at 6:59 am
Spanish and Italian researchers have proven that when honey from strawberry trees, a product typical of Mediterranean areas, is added to colon cancer cells grown in the laboratory, cell ... […]
Anal and Colorectal Cancer Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2019 – 2023
on May 20, 2019 at 3:55 am
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments ... […]
Role of pannexin-1 in the cellular uptake, release and hydrolysis of anandamide by T84 colon cancer cells
on May 20, 2019 at 2:19 am
The large pore ion channel pannexin-1 (Panx1) has been reported to play a role in the cellular uptake and release of anandamide (AEA) in the hippocampus. It is not known whether this is a general ... […]
CARving up colorectal cancer organoids in vitro
on May 19, 2019 at 3:17 pm
Second, the authors optimized their system by retrovirally transducing the organoids with a luciferase-GFP vector to monitor the extent of killing after different time points. On one hand, the ... […]
Colon cancer striking the young in increasing number worldwide
on May 17, 2019 at 8:50 am
HealthDay News The rise in colon cases among younger adults that's been seen in the United States is also occurring in wealthier nations worldwide, new research shows. In the decade leading up to 2014 ... […]
Colorectal cancer incidence on the rise among young adults in several high-income countries
on May 17, 2019 at 12:01 am
The incidence of colon and rectal cancer in adults younger than 50 years has increased substantially over the latest available 10-year period in several high-income countries, going against a ... […]
‘Juvenile lifer’ with colon cancer could be out in 3 years after judge reduces sentence
on May 16, 2019 at 4:01 pm
GRAND RAPIDS, MI -- A man who was just 16 when he killed a Grand Rapids cab driver during a 1993 robbery could be out of prison in about three years as he battles colon cancer. Kent County Circuit ... […]
via Bing News